{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:55:25Z","timestamp":1792011325793,"version":"4.4.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10803-026-07307-2","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:10:09Z","timestamp":1773929409000},"page":"2084-2086","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emerging Discussions on Folinic Acid and Acetaminophen in Autism"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5278-1383","authenticated-orcid":false,"given":"Mustafa","family":"Balkanas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7863-4551","authenticated-orcid":false,"given":"Gizem","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0106-8256","authenticated-orcid":false,"given":"Burak","family":"Do\u011fang\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"14","key":"7307_CR1","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1001\/jama.2024.3172","volume":"331","author":"VH Ahlqvist","year":"2024","unstructured":"Ahlqvist, V. H., Sj\u00f6qvist, H., Dalman, C., Karlsson, H., Stephansson, O., Johansson, S., Magnusson, C., Gardner, R. M., & Lee, B. K. (2024). Acetaminophen use during pregnancy and children\u2019s risk of autism, ADHD, and intellectual disability. Journal of the American Medical Association, 331(14), 1205\u20131214. https:\/\/doi.org\/10.1001\/jama.2024.3172","journal-title":"Journal of the American Medical Association"},{"key":"7307_CR2","unstructured":"American College of Obstetricians and Gynecologists (2025). Acetaminophen use in pregnancy and neurodevelopmental outcomes. Retrieved March 8, 2026, from https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2025\/09\/acetaminophen-use-in-pregnancy-and-neurodevelopmental-outcomes"},{"issue":"1","key":"7307_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13229-021-00464-4","volume":"12","author":"S Antoun","year":"2021","unstructured":"Antoun, S., Ellul, P., Peyre, H., Rosenzwajg, M., Gressens, P., Klatzmann, D., & Delorme, R. (2021). Fever during pregnancy as a risk factor for neurodevelopmental disorders: Results from a systematic review and meta-analysis. Molecular Autism, 12(1), 60. https:\/\/doi.org\/10.1186\/s13229-021-00464-4","journal-title":"Molecular Autism"},{"issue":"5","key":"7307_CR4","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s10578-020-01072-8","volume":"52","author":"N Batebi","year":"2021","unstructured":"Batebi, N., Sanjari Moghaddam, H., Hasanzadeh, A., Fakour, Y., Mohammadi, M. R., & Akhondzadeh, S. (2021). Folinic acid as adjunctive therapy in treatment of inappropriate speech in children with autism: A double-blind and placebo-controlled randomized trial. Child Psychiatry & Human Development, 52(5), 928\u2013938. https:\/\/doi.org\/10.1007\/s10578-020-01072-8","journal-title":"Child Psychiatry & Human Development"},{"issue":"2","key":"7307_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.braindev.2012.10.004","volume":"35","author":"A Estes","year":"2013","unstructured":"Estes, A., Olson, E., Sullivan, K., Greenson, J., Winter, J., Dawson, G., & Munson, J. (2013). Parenting-related stress and psychological distress in mothers of toddlers with autism spectrum disorders. Brain & Development, 35(2), 133\u2013138. https:\/\/doi.org\/10.1016\/j.braindev.2012.10.004","journal-title":"Brain & Development"},{"issue":"2","key":"7307_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/mp.2016.168","volume":"23","author":"RE Frye","year":"2018","unstructured":"Frye, R. E., Slattery, J., Delhey, L., Furgerson, B., Strickland, T., Tippett, M., Sailey, A., Wynne, R., Rose, S., Melnyk, S., James, S. J., Sequeira, J. M., & Quadros, E. V. (2018). Folinic acid improves verbal communication in children with autism and language impairment: A randomized double-blind placebo-controlled trial. Molecular Psychiatry, 23(2), 247\u2013256. https:\/\/doi.org\/10.1038\/mp.2016.168","journal-title":"Molecular Psychiatry"},{"key":"7307_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00431-026-06769-x","volume":"185","author":"PK Panda","year":"2026","unstructured":"Panda, P. K., Sharawat, I. K., Saha, S., Gupta, D., Palayullakandi, A., & Meena, K. (2026). Retraction note: Efficacy of oral folinic acid supplementation in children with autism spectrum disorder: A randomized double-blind, placebo-controlled trial. European Journal of Pediatrics, 185, 109. https:\/\/doi.org\/10.1007\/s00431-026-06769-x","journal-title":"European Journal of Pediatrics"},{"key":"7307_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biochi.2020.04.019","volume":"173","author":"E Renard","year":"2020","unstructured":"Renard, E., Leheup, B., Gu\u00e9ant-Rodriguez, R. M., Oussalah, A., Quadros, E. V., & Gu\u00e9ant, J. L. (2020). Folinic acid improves the score of autism in the EFFET placebo-controlled randomized trial. Biochimie, 173, 57\u201361. https:\/\/doi.org\/10.1016\/j.biochi.2020.04.019","journal-title":"Biochimie"},{"key":"7307_CR10","unstructured":"U.S. Food and Drug Administration. (2025). FDA takes action to make a treatment available for autism symptoms [Press release]. Retrieved March 8, 2026, from https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-action-make-treatment-available-autism-symptoms"},{"issue":"9","key":"7307_CR11","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/nu17091602","volume":"17","author":"C Zhang","year":"2025","unstructured":"Zhang, C., Chen, Y., Hou, F., Li, Y., Wang, W., Guo, L., Zhang, C., Li, L., & Lu, C. (2025). Safety and efficacy of high-dose folinic acid in children with autism: The impact of folate metabolism gene polymorphisms. Nutrients, 17(9), 1602. https:\/\/doi.org\/10.3390\/nu17091602","journal-title":"Nutrients"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-026-07307-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10803-026-07307-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-026-07307-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:59:47Z","timestamp":1779274787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10803-026-07307-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["7307"],"URL":"https:\/\/doi.org\/10.1007\/s10803-026-07307-2","relation":{},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"value":"0162-3257","type":"print"},{"value":"1573-3432","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This Letter to the Editor does not include original data involving human participants; therefore, ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}